NASDAQ: MBRX
Moleculin Biotech Inc Stock Ownership - Who owns Moleculin Biotech?

Insider buying vs selling

Have Moleculin Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Walter V. KlempCEO and President2025-11-047,001$0.50
$3.48kSell
Jonathan P. FosterChief Financial Officer2025-11-045,023$0.50
$2.50kSell
Donald H. PickerChief Science Officer2025-11-042,131$0.50
$1.06kSell
Walter V. KlempCEO and President2025-06-23675,675$0.37
$250.00kBuy
Jonathan P. FosterChief Financial Officer2025-06-23270,270$0.37
$100.00kBuy
Jonathan P. FosterChief Financial Officer2025-06-221,054$0.27
$281.42Sell
Donald H. PickerChief Science Officer2025-06-22430$0.27
$114.81Sell
Walter V. KlempCEO and President2025-06-222,190$0.27
$584.73Sell
Walter V. KlempCEO and President2025-06-20914$0.27
$244.04Sell
Jonathan P. FosterChief Financial Officer2025-06-20661$0.27
$176.49Sell

1 of 2

MBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MBRX insiders and whales buy or sell their stock.

MBRX Shareholders

What type of owners hold Moleculin Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Waldemar Priebe68.32%3,645,573$8.71MInsider
Walter V. Klemp34.49%1,840,356$4.40MInsider
Donald H. Picker10.66%568,771$1.36MInsider
Jonathan P. Foster5.68%303,189$724.62kInsider
Sabby Management LLC1.41%75,021$179.30kInstitution
Geode Capital Management LLC0.61%32,329$77.27kInstitution
Robert E. George0.27%14,660$35.04kInsider
Vanguard Capital Management LLC0.26%13,869$33.15kInstitution
Hrt Financial LP0.26%13,739$32.84kInstitution
Vanguard Fiduciary Trust Co0.11%6,072$14.51kInstitution

1 of 3

MBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MBRX2.33%97.67%Net Buying
INTS5.22%8.60%Net BuyingNet Buying
PHIO0.64%99.36%Net Buying
CVM7.71%92.29%Net BuyingNet Buying
HOTH4.11%42.24%Net Selling

Moleculin Biotech Stock Ownership FAQ

Who owns Moleculin Biotech?

Moleculin Biotech (NASDAQ: MBRX) is owned by 2.85% institutional shareholders, 119.44% Moleculin Biotech insiders, and 0.00% retail investors. Waldemar Priebe is the largest individual Moleculin Biotech shareholder, owning 3.65M shares representing 68.32% of the company. Waldemar Priebe's Moleculin Biotech shares are currently valued at $8.71M.

If you're new to stock investing, here's how to buy Moleculin Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.